000 01538 a2200445 4500
005 20250518071658.0
264 0 _c20200330
008 202003s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/s12885-019-6346-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMolenaar, Remco J
245 0 0 _aStudy protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer.
_h[electronic resource]
260 _bBMC cancer
_cNov 2019
300 _a1133 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650 0 4 _aAdministration, Oral
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBiopsy
650 0 4 _aCystoscopy
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMetformin
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aUrinary Bladder Neoplasms
_xdrug therapy
700 1 _avan Hattum, Jons W
700 1 _aBrummelhuis, Iris S
700 1 _aOddens, Jorg R
700 1 _aSavci-Heijink, C Dilara
700 1 _aBoevé, Egbert R
700 1 _avan der Meer, Saskia A
700 1 _aWitjes, J Fred
700 1 _aPollak, Michael N
700 1 _ade Reijke, Theo M
700 1 _aWilmink, Johanna W
773 0 _tBMC cancer
_gvol. 19
_gno. 1
_gp. 1133
856 4 0 _uhttps://doi.org/10.1186/s12885-019-6346-1
_zAvailable from publisher's website
999 _c30337816
_d30337816